Exploring novel and potent glycogen synthase kinase-3β inhibitors through systematic drug designing approach
Abstract Significant implications of glycogen synthase kinase-3β (GSK-3β) have been reported in various neuronal disorders and malignant cancers. GSK-3β modulates diverse protein targets through phosphorylation, and its aberrant activity leads to neurological complications as well as tumour onset. T...
Saved in:
| Main Authors: | Shabir Ahmad Ganai, Suma Mohan, Shahid Ahmad Padder |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-85868-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Odontogenic differentiation of dental pulp stem cells by glycogen synthase kinase-3β inhibitory peptides
by: Vidhyashree Rajasekar, et al.
Published: (2025-02-01) -
Naringenin may prevent morphine-induced tolerance via inhibiting glycogen synthase kinase-3beta activity in mice
by: Samira Shirooie, et al.
Published: (2024-03-01) -
Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
by: In Won Lee, et al.
Published: (2017-12-01) -
Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors
by: Mohamed A. Kotb, et al.
Published: (2024-11-01) -
Towards the discovery of molecules with anti-COVID-19 activity: Relationships between screening and docking results
by: Dmytro Anokhin, et al.
Published: (2024-06-01)